— Know what they know.
Not Investment Advice
Also trades as: TRSSF (OTC) · $vol 0M · TER.CN (CNQ) · $vol 0M · TSND.TO (TSX) · $vol 0M

TSNDF OTC

TerrAscend Corp.
1W: -19.5% 1M: -20.3% 3M: -12.1% YTD: -30.9%
$0.52
-0.01 (-2.26%)
 
Weekly Expected Move ±12.3%
$0 $0 $1 $1 $1
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Strong Sell · Power 37 · $193.0M mcap · 221M float · 0.121% daily turnover · Short 23% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$193.0M
52W Range0.35-1.45
Volume130,090
Avg Volume267,861
Beta2.02
Dividend—
Analyst Ratings
1 Buy 2 Hold 0 Sell
Consensus Hold
Company Info
CEOZiad Ghanem
Employees1,038
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2017-11-17
77 City Centre Drive, East Tower
Mississauga, ON L5B 1M5
CA
1 855 837 7295
About TerrAscend Corp.

TerrAscend Corp. operates as a cannabis enterprise, handling the cultivation, production, and distribution of various cannabis items throughout Canada and the United States. Its diverse product line encompasses vaporizable products, concentrates, topicals, dried flower, tinctures, and edible formulations. The company markets these offerings under an array of brand names such as Kind Tree Cannabis, GAGE Cannabis, Legend, Valhalla Confections, State Flower Cannabis, Ilera Healthcare, Wana, Cookies, and Lemonnade. Additionally, TerrAscend manages retail cannabis dispensaries operating under banners like Apothecarium, TerrAscend, Pinnacle Emporium, GAGE Cannabis, and State Flower. The firm caters to both medical patients and recreational adult consumers across North America. Incorporated in 2017, TerrAscend maintains its corporate headquarters in King Of Prussia, Pennsylvania.

Recent Insider Trades

NameTypeSharesPriceDate
Ghanem Ziad A-Award 350,000 $0.52 2026-08-10
Collard Craig A A-Award 150,000 $0.26 2026-06-24
GEFEN LYNN K A-Award 275,000 $0.26 2026-06-24
GEFEN LYNN K D-Return 281,250 $1.32 2026-06-24
GEFEN LYNN K A-Award 281,250 $0.26 2026-06-24

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms